{"protocolSection": {"identificationModule": {"nctId": "NCT01555151", "orgStudyIdInfo": {"id": "CQMF149E2201"}, "secondaryIdInfos": [{"id": "2011-005100-14", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler\u00ae Device in Adult and Adolescent Patients With Persistent Asthma", "officialTitle": "A Randomized, Double-blind, Double-dummy, 4-week Treatment, Parallel-group Study to Evaluate the Efficacy and Safety of Two Doses of Mometasone Furoate Delivered Via Concept1 or Twisthaler\u00ae in Adult and Adolescent Patients With Persistent Asthma"}, "statusModule": {"statusVerifiedDate": "2015-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2012-07"}, "primaryCompletionDateStruct": {"date": "2013-07", "type": "ACTUAL"}, "completionDateStruct": {"date": "2013-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2012-03-13", "studyFirstSubmitQcDate": "2012-03-14", "studyFirstPostDateStruct": {"date": "2012-03-15", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-07-06", "resultsFirstSubmitQcDate": "2014-07-06", "resultsFirstPostDateStruct": {"date": "2014-08-01", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-04-10", "lastUpdatePostDateStruct": {"date": "2015-05-01", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of this study is to compare the efficacy, safety and pharmacokinetics of Mometasone furoate delivered via Concept1 device or Twisthaler\u00ae device in adult and adolescent patients with persistent asthma."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 739, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Mometasone furoate 80 \u03bcg", "type": "EXPERIMENTAL", "description": "Description: Mometasone furoate (MF) 800 ug delivered via the Twisthaler\u00ae device for 2 weeks, followed by MF 200 ug delivered via the Twisthaler\u00ae device for 2 weeks or no treatment for 2 weeks, then randomized to MF 80 ug delivered via the Concept1 device for 4 weeks.", "interventionNames": ["Drug: Mometasone furoate", "Device: Concept 1"]}, {"label": "Mometasone furoate 200 \u00b5g", "type": "EXPERIMENTAL", "description": "Mometasone furoate (MF) 800 ug delivered via the Twisthaler\u00ae device for 2 weeks, followed by MF 200 ug delivered via the Twisthaler\u00ae device for 2 weeks or no treatment for 2 weeks, then randomized to MF 200 ug delivered via the Twisthaler\u00ae device for 4 weeks.", "interventionNames": ["Drug: Mometasone furoate", "Device: Twisthaler"]}, {"label": "Mometasone furoate 320 \u00b5g", "type": "EXPERIMENTAL", "description": "Mometasone furoate (MF) 800 ug delivered via the Twisthaler\u00ae device for 2 weeks, followed by MF 200 ug delivered via the Twisthaler\u00ae device for 2 weeks or no treatment for 2 weeks, then randomized to MF 320 ug delivered via the Concept1 device for 4 weeks.", "interventionNames": ["Drug: Mometasone furoate", "Device: Concept 1"]}, {"label": "Mometasone furoate 800 \u00b5g", "type": "EXPERIMENTAL", "description": "Mometasone furoate (MF) 800 ug delivered via the Twisthaler\u00ae device for 2 weeks, followed by MF 200 ug delivered via the Twisthaler\u00ae device for 2 weeks or no treatment for 2 weeks, then randomized to MF 800 ug delivered via the Twisthaler\u00ae device for 4 weeks.", "interventionNames": ["Drug: Mometasone furoate", "Device: Twisthaler"]}], "interventions": [{"type": "DRUG", "name": "Mometasone furoate", "description": "Mometasone furoate (MF) 80 \u00b5g once daily delivered via Concept1 device; MF 200 \u03bcg once daily delivered via Concept1 device; MF 320\u03bcg once daily delivered via Twisthaler\u00ae device or 800 \u03bcg once daily delivered via Twisthaler\u00ae device", "armGroupLabels": ["Mometasone furoate 200 \u00b5g", "Mometasone furoate 320 \u00b5g", "Mometasone furoate 80 \u03bcg", "Mometasone furoate 800 \u00b5g"], "otherNames": ["QMF149"]}, {"type": "DEVICE", "name": "Concept 1", "description": "A single dose dry powder inhaler (SDDPI)", "armGroupLabels": ["Mometasone furoate 320 \u00b5g", "Mometasone furoate 80 \u03bcg"]}, {"type": "DEVICE", "name": "Twisthaler", "description": "A single dose dry powder inhaler (SDDPI)", "armGroupLabels": ["Mometasone furoate 200 \u00b5g", "Mometasone furoate 800 \u00b5g"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Trough Forced Expiratory Volume in 1 Second (FEV1)", "description": "Forced Expiratory Volume in 1 second (FEV1) was measured via spirometry conducted according to internationally accepted standards. Measurements were taken on day 29 after treatment.", "timeFrame": "Day 29"}], "secondaryOutcomes": [{"measure": "Trough Forced Expiratory Volume in 1 Second (FEV1) After Days 8, 15 and 22 of Treatment", "description": "Forced Expiratory Volume in 1 second (FEV1) was measured via spirometry conducted according to internationally accepted standards. Measurements were taken on days 8, 15 and 22 after treatment. Data within 6 hr of rescue medication use is excluded from this analysis.", "timeFrame": "Days 8, 15 and 22"}, {"measure": "Forced Vital Capacity (FVC) at All Time Points", "description": "Forced Vital Capacity (FVC) is the amount of air which can be forcibly exhaled from the lungs after taking the deepest breath possible. Data within 6 hr of rescue medication use is excluded from this analysis. Mixed model: FVC = treatment + gender+ baseline FVC + age + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region.", "timeFrame": "Days 1, 8, 15, 22, 28 and 29 at all time points"}, {"measure": "Forced Expiratory Flow Between 25% and 75% (FEF25-75%) at All Time Points", "description": "The Forced Expiratory Flow (FEF) 25%-75% measurement describes the amount of air expelled from the lungs during the middle half (25% - 75%) of the forced vital capacity test and is measured using spirometry.", "timeFrame": "Days 1, 8, 15, 22, 28 and 29 at all time points"}, {"measure": "Forced Expiratory Volume in 1 Second Forced Vital Capacity (FEV1/FVC) Percent at All Time Points", "description": "Forced Expiratory Volume in 1 second (FEV1)/Forced Vital Capacity (FVC) was measured via spirometry conducted according to internationally accepted standards. Data within 6 hr of rescue medication use is excluded from this analysis.", "timeFrame": "Days 1, 8, 15, 22, 28 and 29 at all time points"}, {"measure": "Change From Baseline in Mean Morning and Evening Peak Expiratory Flow Rate (PEFR) Over 4 Weeks of Treatment", "description": "Peak expiratory flow rate (PEFR) was measured via electronice Peak flow meter by patient at home. Mixed model used: change from baseline in the mean evening PEFR = treatment + age + gender + baseline evening PEFR + level of asthma control + region + center (region)+ error. Center is included as a random effect nested within region.", "timeFrame": "Baseline and week 4"}, {"measure": "Change From Baseline in Asthma Control Questionnaire (ACQ-5) by Visit", "description": "Asthma symptoms were evaluated by the Asthma Control Questionnaire (ACQ). The ACQ-5 has five questions of the asthma symptoms to be answered by the patient. The overall score is the average of the 5 questions; a minimum overall score of 0 = good control of asthma whereas a maximum overall score of 6 = poor control of asthma. A negative change in score indicates improvement in symptoms. MIXED model: Change from baseline in ACQ-5 = treatment + gender + baseline ACQ-5 score + age + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region. - Baseline ACQ-5 is defined as the questionnaire completed on Day 1 (randomization).", "timeFrame": "Baseline, days 8,15,22 and 29"}, {"measure": "Change From Baseline in Mean Daily Number of Puffs of Rescue Medication Over 4 Weeks of Treatment", "description": "Rescue medication data recorded during the 14 day run-in period is used to calculate the baseline. - Total number of puffs of rescue medication per day over the full 4 weeks is calculated and divided by the total number of days with non-missing rescue medication data to derive the mean daily number of puffs of rescue medication taken for the subject. - MIXED model: Change = treatment + gender + baseline mean daily number of puffs + age + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region.", "timeFrame": "Baseline and 4 weeks"}, {"measure": "Percentage of Days With no Rescue Medication Use Over 4 Weeks of Treatment", "description": "Mixed model used: percentage of days with no rescue medication use = treatment + age + gender + baseline percentage of days with no rescue use + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region.\n\nA day with no rescue use is defined from diary data as any day where the subject does not use any puffs of rescue medication.\n\nThe total number of days with no rescue use over the 4 week treatment period is divided by the total number of evaluable days in order to derive the percentage of days with no rescue use.", "timeFrame": "4 weeks"}, {"measure": "Fractional Exhaled Nitric Oxide (FeNO)", "description": "FeNO is widely accepted as a non-invasive marker for airway inflammation such as asthma and conducted according to published guideline. FeNO was measured on days 15 and 29 after treatment.", "timeFrame": "Days 15 and 29"}, {"measure": "Plasma Cortisol Concentrations", "description": "Blood samples were taken from each subject participating in the study post dose at day 1 and week 4. Cortisol concentrations were evaluated. Results are presented as nmol/L", "timeFrame": "Baseline, days 1 and 28"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Males or females who were \u2265 12 years old at the time informed consent was obtained\n* Patients with persistent asthma, diagnosed according to GINA 2010 guideline and who additionally met the following criteria\n* Patients who were receiving ICS treatment up to the maximum dose per day as indicated in the corresponding package leaflet and also a stable ICS regimen for at least 4 weeks prior to screening (Visit 2).\n* Patients whose level of asthma control according to GINA 2010 guideline was \"Partly Controlled\" or \"Uncontrolled\" at screening (Visit 2).\n* Patients with a pre-bronchodilator FEV1 value of \u2264 80% of predicted normal value at screening (Visit 2).\n* Patients who demonstrated an increase of \u2265 12% and 200 mL in FEV1 over prebronchodilator value within 30 minutes after inhalation of 400 \u03bcg of salbutamol (360 \u03bcg of albuterol) at Visit 2 or between Visit 2 and Visit 5.\n* Patients who were confirmed as \"ICS sensitive\" by ACQ-5 and FEV1 at Visit 5.\n\nKey exclusion criteria included:\n\n* Patients diagnosed with COPD as defined by the Global Initiative for Chronic Obstructive Lung Disease, updated 2010.\n* Patients with concomitant pulmonary disease, pulmonary tuberculosis (unless confirmed by chest X-ray to be no longer active), or clinically significant bronchiectasis.\n* Patients with any chronic conditions affecting the respiratory tract (e.g., chronic sinusitis) or chronic lung diseases, which in the opinion of the investigator may interfere with the study evaluation or optimal participation in the study.\n* Patients with seasonal allergy which is likely to deteriorate his/her asthma condition during the study period judged by the investigator.\n* Patients who have had a severe asthma attack/exacerbation requiring hospitalization in the 6 months prior to Visit 1 or any time between Visit 1 and Visit 5 must discontinue from the trial (screening failure).\n* Patients who have had an emergency room visit for an asthma attack/exacerbation within 4 weeks prior to Visit 1 or any time between Visit 1 and Visit 5 must discontinue from the trial (screening failure).\n* Patients who have ever required intubation for a severe asthma attack/exacerbation.\n* Patients who have had a respiratory tract infection within 6 weeks prior to Visit 1, or any time between Visit 1 and Visit 5 must discontinue from the trial (screening failure).\n\nOther protocol-defined inclusion/exclusion criteria may apply", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "12 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Novartis Pharmaceuticals", "affiliation": "Novartis Pharmaceuticals", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Novartis Investigative Site", "city": "Kortrijk", "zip": "8500", "country": "Belgium", "geoPoint": {"lat": 50.82803, "lon": 3.26487}}, {"facility": "Novartis Investigative Site", "city": "Li\u00e8ge", "zip": "4000", "country": "Belgium", "geoPoint": {"lat": 50.63373, "lon": 5.56749}}, {"facility": "Novartis Investigative Site", "city": "Niagara Falls", "state": "Ontario", "zip": "L2G 1J4", "country": "Canada", "geoPoint": {"lat": 43.10012, "lon": -79.06627}}, {"facility": "Novartis Investigative Site", "city": "Windsor", "state": "Ontario", "zip": "N8X 5A6", "country": "Canada", "geoPoint": {"lat": 42.30008, "lon": -83.01654}}, {"facility": "Novartis Investigative Site", "city": "Mirabel", "state": "Quebec", "zip": "J7J 2K8", "country": "Canada", "geoPoint": {"lat": 45.65008, "lon": -74.08251}}, {"facility": "Novartis Investigative Site", "city": "Montreal", "state": "Quebec", "zip": "H3G 1L5", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "Novartis Investigative Site", "city": "Trois-Rivi\u00e8res", "state": "Quebec", "zip": "G8T 7A1", "country": "Canada", "geoPoint": {"lat": 46.34515, "lon": -72.5477}}, {"facility": "Novartis Investigative Site", "city": "Quebec", "zip": "GIV 4M6", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"facility": "Novartis Investigative Site", "city": "Kohtla-J\u00e4rve", "zip": "30321", "country": "Estonia", "geoPoint": {"lat": 59.39861, "lon": 27.27306}}, {"facility": "Novartis Investigative Site", "city": "Tallinn", "zip": "10138", "country": "Estonia", "geoPoint": {"lat": 59.43696, "lon": 24.75353}}, {"facility": "Novartis Investigative Site", "city": "Tartu", "zip": "51014", "country": "Estonia", "geoPoint": {"lat": 58.38062, "lon": 26.72509}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10117", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10696", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10717", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12203", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "14050", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "14057", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Dresden", "zip": "01069", "country": "Germany", "geoPoint": {"lat": 51.05089, "lon": 13.73832}}, {"facility": "Novartis Investigative Site", "city": "Essen", "zip": "45355", "country": "Germany", "geoPoint": {"lat": 51.45657, "lon": 7.01228}}, {"facility": "Novartis Investigative Site", "city": "Goch", "zip": "47574", "country": "Germany", "geoPoint": {"lat": 51.67873, "lon": 6.15895}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "20253", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hamburg", "zip": "22143", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"facility": "Novartis Investigative Site", "city": "Hannover", "zip": "30317", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "4207", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Luebeck", "zip": "23562", "country": "Germany", "geoPoint": {"lat": 53.86893, "lon": 10.68729}}, {"facility": "Novartis Investigative Site", "city": "Muenchen", "zip": "80539", "country": "Germany", "geoPoint": {"lat": 51.60698, "lon": 13.31243}}, {"facility": "Novartis Investigative Site", "city": "Reinfeld", "zip": "23858", "country": "Germany", "geoPoint": {"lat": 53.83184, "lon": 10.49126}}, {"facility": "Novartis Investigative Site", "city": "Schwerin", "zip": "19055", "country": "Germany", "geoPoint": {"lat": 53.62937, "lon": 11.41316}}, {"facility": "Novartis Investigative Site", "city": "Baja", "zip": "6500", "country": "Hungary", "geoPoint": {"lat": 46.17496, "lon": 18.95639}}, {"facility": "Novartis Investigative Site", "city": "Balassagyarmat", "zip": "2660", "country": "Hungary", "geoPoint": {"lat": 48.07296, "lon": 19.29614}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1033", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1036", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1041", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1121", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1122", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1135", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Cegled", "zip": "2700", "country": "Hungary", "geoPoint": {"lat": 47.17266, "lon": 19.79952}}, {"facility": "Novartis Investigative Site", "city": "Debrecen", "zip": "4031", "country": "Hungary", "geoPoint": {"lat": 47.53333, "lon": 21.63333}}, {"facility": "Novartis Investigative Site", "city": "Godollo", "zip": "2100", "country": "Hungary", "geoPoint": {"lat": 47.59657, "lon": 19.35515}}, {"facility": "Novartis Investigative Site", "city": "Gyor", "zip": "9024", "country": "Hungary", "geoPoint": {"lat": 47.68333, "lon": 17.63512}}, {"facility": "Novartis Investigative Site", "city": "Gyula", "zip": "5700", "country": "Hungary", "geoPoint": {"lat": 46.65, "lon": 21.28333}}, {"facility": "Novartis Investigative Site", "city": "Kistelek", "zip": "6760", "country": "Hungary", "geoPoint": {"lat": 46.4725, "lon": 19.97972}}, {"facility": "Novartis Investigative Site", "city": "Komarom", "zip": "2900", "country": "Hungary", "geoPoint": {"lat": 47.74318, "lon": 18.11913}}, {"facility": "Novartis Investigative Site", "city": "Mak\u00f3", "zip": "6900", "country": "Hungary", "geoPoint": {"lat": 46.21667, "lon": 20.48333}}, {"facility": "Novartis Investigative Site", "city": "Mohacs", "zip": "7700", "country": "Hungary", "geoPoint": {"lat": 45.99306, "lon": 18.68306}}, {"facility": "Novartis Investigative Site", "city": "Monor", "zip": "2200", "country": "Hungary", "geoPoint": {"lat": 47.35133, "lon": 19.44733}}, {"facility": "Novartis Investigative Site", "city": "Mosonmagyarovar", "zip": "9200", "country": "Hungary", "geoPoint": {"lat": 47.86789, "lon": 17.26994}}, {"facility": "Novartis Investigative Site", "city": "Nagykanizsa", "zip": "8800", "country": "Hungary", "geoPoint": {"lat": 46.45347, "lon": 16.99104}}, {"facility": "Novartis Investigative Site", "city": "Nyiregyhaza", "zip": "4400", "country": "Hungary", "geoPoint": {"lat": 47.95539, "lon": 21.71671}}, {"facility": "Novartis Investigative Site", "city": "Szeged", "zip": "6722", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Novartis Investigative Site", "city": "Szikszo", "zip": "3800", "country": "Hungary", "geoPoint": {"lat": 48.2, "lon": 20.93333}}, {"facility": "Novartis Investigative Site", "city": "Szombathely", "zip": "9700", "country": "Hungary", "geoPoint": {"lat": 47.23088, "lon": 16.62155}}, {"facility": "Novartis Investigative Site", "city": "Sz\u00e1zhalombatta", "zip": "2440", "country": "Hungary", "geoPoint": {"lat": 47.32579, "lon": 18.92141}}, {"facility": "Novartis Investigative Site", "city": "Torokbalint", "zip": "2045", "country": "Hungary", "geoPoint": {"lat": 47.42931, "lon": 18.91356}}, {"facility": "Novartis Investigative Site", "city": "Bangalore", "state": "Karnataka", "zip": "560 010", "country": "India", "geoPoint": {"lat": 12.97194, "lon": 77.59369}}, {"facility": "Novartis Investigative Site", "city": "Bangalore", "state": "Karnataka", "zip": "560043", "country": "India", "geoPoint": {"lat": 12.97194, "lon": 77.59369}}, {"facility": "Novartis Investigative Site", "city": "Bangalore", "state": "Karnataka", "zip": "560054", "country": "India", "geoPoint": {"lat": 12.97194, "lon": 77.59369}}, {"facility": "Novartis Investigative Site", "city": "Mysore", "state": "Karnataka", "zip": "570004", "country": "India", "geoPoint": {"lat": 12.29791, "lon": 76.63925}}, {"facility": "Novartis Investigative Site", "city": "Pune", "state": "Maharashtra", "zip": "411 014", "country": "India", "geoPoint": {"lat": 18.51957, "lon": 73.85535}}, {"facility": "Novartis Investigative Site", "city": "Coimbatore", "state": "Tamil Nadu", "zip": "641 045.", "country": "India", "geoPoint": {"lat": 11.00555, "lon": 76.96612}}, {"facility": "Novartis Investigative Site", "city": "Vellore", "state": "Tamil Nadu", "zip": "632 004", "country": "India", "geoPoint": {"lat": 12.9184, "lon": 79.13255}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "zip": "302001", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Karamsad", "zip": "388225", "country": "India", "geoPoint": {"lat": 22.54243, "lon": 72.90392}}, {"facility": "Novartis Investigative Site", "city": "Ludhiana", "zip": "141001", "country": "India", "geoPoint": {"lat": 30.91204, "lon": 75.85379}}, {"facility": "Novartis Investigative Site", "city": "Nagpur", "zip": "400012", "country": "India", "geoPoint": {"lat": 21.14631, "lon": 79.08491}}, {"facility": "Novartis Investigative Site", "city": "Thrissur", "zip": "680002", "country": "India", "geoPoint": {"lat": 10.51667, "lon": 76.21667}}, {"facility": "Novartis Investigative Site", "city": "Toon-shi", "state": "Ehime", "zip": "791-0281", "country": "Japan", "geoPoint": {"lat": 33.79427, "lon": 132.89011}}, {"facility": "Novartis Investigative Site", "city": "Mizunami-city", "state": "Gifu", "zip": "509-6134", "country": "Japan", "geoPoint": {"lat": 35.36667, "lon": 137.25}}, {"facility": "Novartis Investigative Site", "city": "Fukuyama-shi", "state": "Hiroshima", "zip": "720-0001", "country": "Japan", "geoPoint": {"lat": 34.48333, "lon": 133.36667}}, {"facility": "Novartis Investigative Site", "city": "Kitahiroshima-shi", "state": "Hokkaido", "zip": "061-1121", "country": "Japan", "geoPoint": {"lat": 42.97583, "lon": 141.56722}}, {"facility": "Novartis Investigative Site", "city": "Obihiro-shi", "state": "Hokkaido", "zip": "080-0013", "country": "Japan", "geoPoint": {"lat": 42.91722, "lon": 143.20444}}, {"facility": "Novartis Investigative Site", "city": "Obihiro-shi", "state": "Hokkaido", "zip": "080-0805", "country": "Japan", "geoPoint": {"lat": 42.91722, "lon": 143.20444}}, {"facility": "Novartis Investigative Site", "city": "Sapporo-shi", "state": "Hokkaido", "zip": "004-0022", "country": "Japan", "geoPoint": {"lat": 43.06667, "lon": 141.35}}, {"facility": "Novartis Investigative Site", "city": "Sapporo-shi", "state": "Hokkaido", "zip": "065-0025", "country": "Japan", "geoPoint": {"lat": 43.06667, "lon": 141.35}}, {"facility": "Novartis Investigative Site", "city": "Tomakomai", "state": "Hokkaido", "zip": "053-8506", "country": "Japan", "geoPoint": {"lat": 42.63694, "lon": 141.60333}}, {"facility": "Novartis Investigative Site", "city": "Kobe-shi", "state": "Hyogo", "zip": "653-0021", "country": "Japan", "geoPoint": {"lat": 34.6913, "lon": 135.183}}, {"facility": "Novartis Investigative Site", "city": "Kawasaki-shi", "state": "Kanagawa", "zip": "211-0041", "country": "Japan", "geoPoint": {"lat": 35.52056, "lon": 139.71722}}, {"facility": "Novartis Investigative Site", "city": "Kurashiki-city", "state": "Okayama", "zip": "712-8064", "country": "Japan", "geoPoint": {"lat": 34.58333, "lon": 133.76667}}, {"facility": "Novartis Investigative Site", "city": "Kurashiki-shi", "state": "Okayama", "zip": "713-8103", "country": "Japan", "geoPoint": {"lat": 34.58333, "lon": 133.76667}}, {"facility": "Novartis Investigative Site", "city": "Osaka-city", "state": "Osaka", "zip": "530-0001", "country": "Japan", "geoPoint": {"lat": 34.69374, "lon": 135.50218}}, {"facility": "Novartis Investigative Site", "city": "Sakai-city", "state": "Osaka", "zip": "591-8555", "country": "Japan", "geoPoint": {"lat": 34.58333, "lon": 135.46667}}, {"facility": "Novartis Investigative Site", "city": "Suita", "state": "Osaka", "zip": "565-0853", "country": "Japan", "geoPoint": {"lat": 34.76143, "lon": 135.51567}}, {"facility": "Novartis Investigative Site", "city": "Toyonaka-city", "state": "Osaka", "zip": "560-0082", "country": "Japan", "geoPoint": {"lat": 34.78244, "lon": 135.46932}}, {"facility": "Novartis Investigative Site", "city": "Chiyoda-ku", "state": "Tokyo", "zip": "102-0083", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Chuo-ku", "state": "Tokyo", "zip": "103-0027", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "Novartis Investigative Site", "city": "Chuo-ku", "state": "Tokyo", "zip": "103-0028", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "Novartis Investigative Site", "city": "Hachioji-city", "state": "Tokyo", "zip": "192-0032", "country": "Japan", "geoPoint": {"lat": 35.65583, "lon": 139.32389}}, {"facility": "Novartis Investigative Site", "city": "Shinagawa-ku", "state": "Tokyo", "zip": "140-0011", "country": "Japan", "geoPoint": {"lat": 33.63627, "lon": 133.00572}}, {"facility": "Novartis Investigative Site", "city": "Tachikawa", "state": "Tokyo", "zip": "190-0013", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Toshima-ku", "state": "Tokyo", "zip": "171-0014", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Rezekne", "state": "LV", "zip": "LV-4600", "country": "Latvia", "geoPoint": {"lat": 56.51025, "lon": 27.33994}}, {"facility": "Novartis Investigative Site", "city": "Riga", "state": "LV", "zip": "1002", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Talsi", "state": "LV", "zip": "LV3201", "country": "Latvia", "geoPoint": {"lat": 57.24562, "lon": 22.58137}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "1002", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "LV-1004", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "LV-1038", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "state": "LT", "zip": "44320", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Klaipeda", "state": "LT", "zip": "92288", "country": "Lithuania", "geoPoint": {"lat": 55.70888, "lon": 21.14311}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "zip": "50009", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Klaipeda", "zip": "LT-92231", "country": "Lithuania", "geoPoint": {"lat": 55.70888, "lon": 21.14311}}, {"facility": "Novartis Investigative Site", "city": "Vilnius", "zip": "LT-08661", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "Novartis Investigative Site", "city": "Kuching", "state": "Sarawak", "zip": "93586", "country": "Malaysia", "geoPoint": {"lat": 1.54999, "lon": 110.33333}}, {"facility": "Novartis Investigative Site", "city": "Kota Kinabalu", "zip": "88586", "country": "Malaysia", "geoPoint": {"lat": 5.9749, "lon": 116.0724}}, {"facility": "Novartis Investigative Site", "city": "Kuala Lumpur", "zip": "59100", "country": "Malaysia", "geoPoint": {"lat": 3.1412, "lon": 101.68653}}, {"facility": "Novartis Investigative Site", "city": "Almere", "state": "The Netherlands", "zip": "1311 RL", "country": "Netherlands", "geoPoint": {"lat": 52.37535, "lon": 5.25295}}, {"facility": "Novartis Investigative Site", "city": "Eindhoven", "state": "The Netherlands", "zip": "5616GB", "country": "Netherlands", "geoPoint": {"lat": 51.44083, "lon": 5.47778}}, {"facility": "Novartis Investigative Site", "city": "Leiderdorp", "state": "The Netherlands", "zip": "2352 RA", "country": "Netherlands", "geoPoint": {"lat": 52.15833, "lon": 4.52917}}, {"facility": "Novartis Investigative Site", "city": "Rotterdam", "state": "The Netherlands", "zip": "3021 HC", "country": "Netherlands", "geoPoint": {"lat": 51.9225, "lon": 4.47917}}, {"facility": "Novartis Investigative Site", "city": "Zoetermeer", "state": "The Netherlands", "zip": "2724 EK", "country": "Netherlands", "geoPoint": {"lat": 52.0575, "lon": 4.49306}}, {"facility": "Novartis Investigative Site", "city": "Geleen", "zip": "6166 GR", "country": "Netherlands", "geoPoint": {"lat": 50.97417, "lon": 5.82917}}, {"facility": "Novartis Investigative Site", "city": "Hoofddorp", "zip": "2134 TM", "country": "Netherlands", "geoPoint": {"lat": 52.3025, "lon": 4.68889}}, {"facility": "Novartis Investigative Site", "city": "Bialystok", "zip": "15-445", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Novartis Investigative Site", "city": "Gdansk", "zip": "80-952", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"facility": "Novartis Investigative Site", "city": "Katowice", "zip": "40-954", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"facility": "Novartis Investigative Site", "city": "Krakow", "zip": "30-510", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Novartis Investigative Site", "city": "Krakow", "zip": "31-637", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Novartis Investigative Site", "city": "Lodz", "zip": "95-100", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60-693", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Skierniewice", "zip": "96-100", "country": "Poland", "geoPoint": {"lat": 51.95485, "lon": 20.15837}}, {"facility": "Novartis Investigative Site", "city": "Warszawa", "zip": "01-868", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "Novartis Investigative Site", "city": "Wroclaw", "zip": "50-445", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "Novartis Investigative Site", "city": "St. Petersburg", "state": "Nizhny Novgorod", "zip": "194356", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Ekaterinburg", "state": "Russia", "zip": "620109", "country": "Russian Federation", "geoPoint": {"lat": 56.8519, "lon": 60.6122}}, {"facility": "Novartis Investigative Site", "city": "Kazan", "state": "Russia", "zip": "420012", "country": "Russian Federation", "geoPoint": {"lat": 55.78874, "lon": 49.12214}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "state": "Russia", "zip": "109240", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Sankt-Peterburg", "state": "Russia", "zip": "197022", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St. Petersburg", "state": "Russia", "zip": "194044", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Yaroslavl", "zip": "150003", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "Novartis Investigative Site", "city": "Bojnice", "state": "Slovak Republic", "zip": "972 01", "country": "Slovakia", "geoPoint": {"lat": 48.78511, "lon": 18.5864}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "state": "Slovak Republic", "zip": "831 03", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "state": "Slovak Republic", "zip": "83101", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "state": "Slovak Republic", "zip": "040 01", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Levice", "state": "Slovak republic", "zip": "934 01", "country": "Slovakia", "geoPoint": {"lat": 48.21563, "lon": 18.60705}}, {"facility": "Novartis Investigative Site", "city": "Liptovsky Hradok", "state": "Slovak Republic", "zip": "033 01", "country": "Slovakia", "geoPoint": {"lat": 49.03962, "lon": 19.72335}}, {"facility": "Novartis Investigative Site", "city": "Nitra", "state": "Slovak Republic", "zip": "949 01", "country": "Slovakia", "geoPoint": {"lat": 48.30763, "lon": 18.08453}}, {"facility": "Novartis Investigative Site", "city": "Roznava", "state": "Slovak Republic", "zip": "4801", "country": "Slovakia", "geoPoint": {"lat": 48.66009, "lon": 20.53758}}, {"facility": "Novartis Investigative Site", "city": "Surany", "state": "Slovak Republic", "zip": "942 01", "country": "Slovakia", "geoPoint": {"lat": 48.08613, "lon": 18.18447}}, {"facility": "Novartis Investigative Site", "city": "Trencin", "state": "Slovak Republic", "zip": "91108", "country": "Slovakia", "geoPoint": {"lat": 48.89452, "lon": 18.04436}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "zip": "833 40", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Martin", "zip": "036 59", "country": "Slovakia", "geoPoint": {"lat": 49.06651, "lon": 18.92399}}, {"facility": "Novartis Investigative Site", "city": "Poprad", "zip": "05845", "country": "Slovakia", "geoPoint": {"lat": 49.06144, "lon": 20.29798}}, {"facility": "Novartis Investigative Site", "city": "Ruzomberok", "zip": "034 26", "country": "Slovakia", "geoPoint": {"lat": 49.0748, "lon": 19.30751}}, {"facility": "Novartis Investigative Site", "city": "Muang", "zip": "11000", "country": "Thailand"}, {"facility": "Novartis Investigative Site", "city": "Muang", "zip": "30000", "country": "Thailand"}, {"facility": "Novartis Investigative Site", "city": "Rajathevee", "zip": "10400", "country": "Thailand"}, {"facility": "Novartis Investigative Site", "city": "Ratchathewi", "zip": "10400", "country": "Thailand", "geoPoint": {"lat": 13.759, "lon": 100.53358}}, {"facility": "Novartis Investigative Site", "city": "Adana", "zip": "01330", "country": "Turkey", "geoPoint": {"lat": 37.00167, "lon": 35.32889}}, {"facility": "Novartis Investigative Site", "city": "Bursa", "zip": "16059", "country": "Turkey", "geoPoint": {"lat": 40.19559, "lon": 29.06013}}, {"facility": "Novartis Investigative Site", "city": "Gaziantep", "zip": "27310", "country": "Turkey", "geoPoint": {"lat": 37.05944, "lon": 37.3825}}, {"facility": "Novartis Investigative Site", "city": "Istanbul", "zip": "35100", "country": "Turkey", "geoPoint": {"lat": 41.01384, "lon": 28.94966}}, {"facility": "Novartis Investigative Site", "city": "Izmir", "zip": "34890", "country": "Turkey", "geoPoint": {"lat": 38.41273, "lon": 27.13838}}, {"facility": "Novartis Investigative Site", "city": "Izmir", "zip": "35040", "country": "Turkey", "geoPoint": {"lat": 38.41273, "lon": 27.13838}}, {"facility": "Novartis Investigative Site", "city": "Talas / Kayseri", "zip": "38039", "country": "Turkey"}, {"facility": "Novartis Investigative Site", "city": "Dnipropetrovsk", "zip": "49066", "country": "Ukraine", "geoPoint": {"lat": 48.4593, "lon": 35.03864}}, {"facility": "Novartis Investigative Site", "city": "Dnipropetrovsk", "zip": "49074", "country": "Ukraine", "geoPoint": {"lat": 48.4593, "lon": 35.03864}}, {"facility": "Novartis Investigative Site", "city": "Donetsk", "zip": "83003", "country": "Ukraine", "geoPoint": {"lat": 48.023, "lon": 37.80224}}, {"facility": "Novartis Investigative Site", "city": "Kharkiv", "zip": "61039", "country": "Ukraine", "geoPoint": {"lat": 49.98081, "lon": 36.25272}}, {"facility": "Novartis Investigative Site", "city": "Kharkiv", "zip": "61098", "country": "Ukraine", "geoPoint": {"lat": 49.98081, "lon": 36.25272}}, {"facility": "Novartis Investigative Site", "city": "Kharkiv", "zip": "61124", "country": "Ukraine", "geoPoint": {"lat": 49.98081, "lon": 36.25272}}, {"facility": "Novartis Investigative Site", "city": "Kyiv", "zip": "04050", "country": "Ukraine", "geoPoint": {"lat": 50.45466, "lon": 30.5238}}, {"facility": "Novartis Investigative Site", "city": "Kyiv", "zip": "1004", "country": "Ukraine", "geoPoint": {"lat": 50.45466, "lon": 30.5238}}, {"facility": "Novartis Investigative Site", "city": "Kyiv", "zip": "3680", "country": "Ukraine", "geoPoint": {"lat": 50.45466, "lon": 30.5238}}, {"facility": "Novartis Investigative Site", "city": "Kyiv", "zip": "4050", "country": "Ukraine", "geoPoint": {"lat": 50.45466, "lon": 30.5238}}, {"facility": "Novartis Investigative Site", "city": "Vinnytsia", "zip": "20129", "country": "Ukraine", "geoPoint": {"lat": 49.23278, "lon": 28.48097}}, {"facility": "Novartis Investigative Site", "city": "Vinnytsia", "zip": "21029", "country": "Ukraine", "geoPoint": {"lat": 49.23278, "lon": 28.48097}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "FG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "FG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "FG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "188"}, {"groupId": "FG001", "numSubjects": "181"}, {"groupId": "FG002", "numSubjects": "184"}, {"groupId": "FG003", "numSubjects": "186"}]}, {"type": "Safety Set (SAF)", "achievements": [{"groupId": "FG000", "numSubjects": "186"}, {"groupId": "FG001", "numSubjects": "180"}, {"groupId": "FG002", "numSubjects": "183"}, {"groupId": "FG003", "numSubjects": "186"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "175"}, {"groupId": "FG001", "numSubjects": "173"}, {"groupId": "FG002", "numSubjects": "178"}, {"groupId": "FG003", "numSubjects": "176"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "13"}, {"groupId": "FG001", "numSubjects": "8"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "10"}]}], "dropWithdraws": [{"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "2"}]}, {"type": "Administrative", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "0"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "3"}, {"groupId": "FG003", "numSubjects": "5"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "2"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "BG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "BG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "BG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}, {"id": "BG004", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "188"}, {"groupId": "BG001", "value": "181"}, {"groupId": "BG002", "value": "184"}, {"groupId": "BG003", "value": "186"}, {"groupId": "BG004", "value": "739"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "44.4", "spread": "16.33"}, {"groupId": "BG001", "value": "45.9", "spread": "15.56"}, {"groupId": "BG002", "value": "46.0", "spread": "16.18"}, {"groupId": "BG003", "value": "45.5", "spread": "16.57"}, {"groupId": "BG004", "value": "45.4", "spread": "16.15"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "98"}, {"groupId": "BG001", "value": "94"}, {"groupId": "BG002", "value": "113"}, {"groupId": "BG003", "value": "97"}, {"groupId": "BG004", "value": "402"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "90"}, {"groupId": "BG001", "value": "87"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "89"}, {"groupId": "BG004", "value": "337"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Trough Forced Expiratory Volume in 1 Second (FEV1)", "description": "Forced Expiratory Volume in 1 second (FEV1) was measured via spirometry conducted according to internationally accepted standards. Measurements were taken on day 29 after treatment.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Liters", "timeFrame": "Day 29", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "171"}, {"groupId": "OG001", "value": "165"}, {"groupId": "OG002", "value": "172"}, {"groupId": "OG003", "value": "173"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.139", "spread": "0.0281"}, {"groupId": "OG001", "value": "2.071", "spread": "0.0283"}, {"groupId": "OG002", "value": "2.187", "spread": "0.0281"}, {"groupId": "OG003", "value": "2.162", "spread": "0.0279"}]}]}]}, {"type": "SECONDARY", "title": "Trough Forced Expiratory Volume in 1 Second (FEV1) After Days 8, 15 and 22 of Treatment", "description": "Forced Expiratory Volume in 1 second (FEV1) was measured via spirometry conducted according to internationally accepted standards. Measurements were taken on days 8, 15 and 22 after treatment. Data within 6 hr of rescue medication use is excluded from this analysis.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Liters", "timeFrame": "Days 8, 15 and 22", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "179"}, {"groupId": "OG001", "value": "173"}, {"groupId": "OG002", "value": "181"}, {"groupId": "OG003", "value": "181"}]}], "classes": [{"title": "Day 8 (n=178,173,181,181)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.069", "spread": "0.0252"}, {"groupId": "OG001", "value": "2.057", "spread": "0.0253"}, {"groupId": "OG002", "value": "2.113", "spread": "0.0251"}, {"groupId": "OG003", "value": "2.111", "spread": "0.0250"}]}]}, {"title": "Day 15 (n=179,171,177,178)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.095", "spread": "0.0254"}, {"groupId": "OG001", "value": "2.048", "spread": "0.0258"}, {"groupId": "OG002", "value": "2.134", "spread": "0.0257"}, {"groupId": "OG003", "value": "2.135", "spread": "0.0255"}]}]}, {"title": "Day 22 (n=174,170,177,177)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.126", "spread": "0.0284"}, {"groupId": "OG001", "value": "2.071", "spread": "0.0286"}, {"groupId": "OG002", "value": "2.175", "spread": "0.0283"}, {"groupId": "OG003", "value": "2.146", "spread": "0.0282"}]}]}]}, {"type": "SECONDARY", "title": "Forced Vital Capacity (FVC) at All Time Points", "description": "Forced Vital Capacity (FVC) is the amount of air which can be forcibly exhaled from the lungs after taking the deepest breath possible. Data within 6 hr of rescue medication use is excluded from this analysis. Mixed model: FVC = treatment + gender+ baseline FVC + age + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Liters", "timeFrame": "Days 1, 8, 15, 22, 28 and 29 at all time points", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}, {"groupId": "OG001", "value": "172"}, {"groupId": "OG002", "value": "179"}, {"groupId": "OG003", "value": "174"}]}], "classes": [{"title": "Day 1/30 min post-dose (n=172,172,175,173)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.892", "spread": "0.0208"}, {"groupId": "OG001", "value": "2.893", "spread": "0.0207"}, {"groupId": "OG002", "value": "2.861", "spread": "0.0209"}, {"groupId": "OG003", "value": "2.897", "spread": "0.0208"}]}]}, {"title": "Day 1/1 hr post-dose (n=178,169,174,175)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.930", "spread": "0.0234"}, {"groupId": "OG001", "value": "2.913", "spread": "0.0238"}, {"groupId": "OG002", "value": "2.943", "spread": "0.0238"}, {"groupId": "OG003", "value": "2.946", "spread": "0.0235"}]}]}, {"title": "Day 8/50 min pre-dose (n=174,171,179,174)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.111", "spread": "0.0325"}, {"groupId": "OG001", "value": "3.096", "spread": "0.0325"}, {"groupId": "OG002", "value": "3.134", "spread": "0.0321"}, {"groupId": "OG003", "value": "3.139", "spread": "0.0324"}]}]}, {"title": "Day 8/15 min pre-dose (n=176,172,179,174)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.099", "spread": "0.0324"}, {"groupId": "OG001", "value": "3.074", "spread": "0.0324"}, {"groupId": "OG002", "value": "3.121", "spread": "0.0321"}, {"groupId": "OG003", "value": "3.125", "spread": "0.0323"}]}]}, {"title": "Day 15 /50 min pre-dose (n=175,169,170,169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.134", "spread": "0.0342"}, {"groupId": "OG001", "value": "3.090", "spread": "0.0347"}, {"groupId": "OG002", "value": "3.168", "spread": "0.0348"}, {"groupId": "OG003", "value": "3.155", "spread": "0.0348"}]}]}, {"title": "Day 15/15 min pre-dose (n=176,168,176,167)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.109", "spread": "0.0343"}, {"groupId": "OG001", "value": "3.076", "spread": "0.0348"}, {"groupId": "OG002", "value": "3.137", "spread": "0.0345"}, {"groupId": "OG003", "value": "3.127", "spread": "0.0348"}]}]}, {"title": "Day 22/50 min pre-dose (n=172,167,174,169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.136", "spread": "0.0356"}, {"groupId": "OG001", "value": "3.091", "spread": "0.0359"}, {"groupId": "OG002", "value": "3.203", "spread": "0.0355"}, {"groupId": "OG003", "value": "3.152", "spread": "0.0357"}]}]}, {"title": "Day 22/15 min pre-dose (n=169,170,174,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.134", "spread": "0.0365"}, {"groupId": "OG001", "value": "3.096", "spread": "0.0363"}, {"groupId": "OG002", "value": "3.198", "spread": "0.0362"}, {"groupId": "OG003", "value": "3.157", "spread": "0.0361"}]}]}, {"title": "Day 28/50 min pre-dose (n=172,168,176,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.146", "spread": "0.0342"}, {"groupId": "OG001", "value": "3.115", "spread": "0.0345"}, {"groupId": "OG002", "value": "3.184", "spread": "0.0340"}, {"groupId": "OG003", "value": "3.180", "spread": "0.0342"}]}]}, {"title": "Day 28/15 min pre-dose (n=170,165,174, 170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.135", "spread": "0.0345"}, {"groupId": "OG001", "value": "3.095", "spread": "0.0348"}, {"groupId": "OG002", "value": "3.153", "spread": "0.0343"}, {"groupId": "OG003", "value": "3.161", "spread": "0.0344"}]}]}, {"title": "Day 28/30 min post-dose (n=175,166,174,170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.132", "spread": "0.0341"}, {"groupId": "OG001", "value": "3.092", "spread": "0.0346"}, {"groupId": "OG002", "value": "3.151", "spread": "0.0343"}, {"groupId": "OG003", "value": "3.184", "spread": "0.0343"}]}]}, {"title": "Day 28/30 min post-dose (n=173,167,172,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.140", "spread": "0.0351"}, {"groupId": "OG001", "value": "3.084", "spread": "0.0353"}, {"groupId": "OG002", "value": "3.158", "spread": "0.0353"}, {"groupId": "OG003", "value": "3.161", "spread": "0.0350"}]}]}, {"title": "Day 29/23hr 10 min post-dose (n=173,162,172,168)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.160", "spread": "0.0342"}, {"groupId": "OG001", "value": "3.113", "spread": "0.0348"}, {"groupId": "OG002", "value": "3.216", "spread": "0.0343"}, {"groupId": "OG003", "value": "3.194", "spread": "0.0344"}]}]}, {"title": "Day 29/23hr 45 min post-dose (n=172,161, 175,170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.165", "spread": "0.0355"}, {"groupId": "OG001", "value": "3.090", "spread": "0.0363"}, {"groupId": "OG002", "value": "3.192", "spread": "0.0353"}, {"groupId": "OG003", "value": "3.158", "spread": "0.0355"}]}]}]}, {"type": "SECONDARY", "title": "Forced Expiratory Flow Between 25% and 75% (FEF25-75%) at All Time Points", "description": "The Forced Expiratory Flow (FEF) 25%-75% measurement describes the amount of air expelled from the lungs during the middle half (25% - 75%) of the forced vital capacity test and is measured using spirometry.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Liters per second", "timeFrame": "Days 1, 8, 15, 22, 28 and 29 at all time points", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}, {"groupId": "OG001", "value": "172"}, {"groupId": "OG002", "value": "179"}, {"groupId": "OG003", "value": "174"}]}], "classes": [{"title": "Day 1/30 min post-dose (n=172,172,175,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.308", "spread": "0.0181"}, {"groupId": "OG001", "value": "1.300", "spread": "0.0182"}, {"groupId": "OG002", "value": "1.309", "spread": "0.0182"}, {"groupId": "OG003", "value": "1.308", "spread": "0.0182"}]}]}, {"title": "Day 1/1 hr post-dose (n=178,169,174,174)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.337", "spread": "0.0197"}, {"groupId": "OG001", "value": "1.327", "spread": "0.0201"}, {"groupId": "OG002", "value": "1.316", "spread": "0.0201"}, {"groupId": "OG003", "value": "1.345", "spread": "0.0199"}]}]}, {"title": "Day 8/50 min pre-dose (n=173,171,179,174)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.457", "spread": "0.0323"}, {"groupId": "OG001", "value": "1.449", "spread": "0.0322"}, {"groupId": "OG002", "value": "1.519", "spread": "0.0317"}, {"groupId": "OG003", "value": "1.525", "spread": "0.0321"}]}]}, {"title": "Day 8/15 min pre-dose (n=175,172,179,173)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.458", "spread": "0.0329"}, {"groupId": "OG001", "value": "1.466", "spread": "0.0328"}, {"groupId": "OG002", "value": "1.542", "spread": "0.0325"}, {"groupId": "OG003", "value": "1.566", "spread": "0.0328"}]}]}, {"title": "Day 15 /50 min pre-dose (n=175,169,170,169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.509", "spread": "0.0317"}, {"groupId": "OG001", "value": "1.430", "spread": "0.0321"}, {"groupId": "OG002", "value": "1.514", "spread": "0.0320"}, {"groupId": "OG003", "value": "1.544", "spread": "0.0321"}]}]}, {"title": "Day 15/15 min pre-dose (n=175,168,176,167)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.494", "spread": "0.0322"}, {"groupId": "OG001", "value": "1.414", "spread": "0.0326"}, {"groupId": "OG002", "value": "1.520", "spread": "0.0321"}, {"groupId": "OG003", "value": "1.561", "spread": "0.0327"}]}]}, {"title": "Day 22/50 min pre-dose (n=171,167,174,169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.511", "spread": "0.0350"}, {"groupId": "OG001", "value": "1.440", "spread": "0.0353"}, {"groupId": "OG002", "value": "1.565", "spread": "0.0348"}, {"groupId": "OG003", "value": "1.555", "spread": "0.0351"}]}]}, {"title": "Day 22/15 min pre-dose (n=168,170,174,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.540", "spread": "0.0365"}, {"groupId": "OG001", "value": "1.476", "spread": "0.0362"}, {"groupId": "OG002", "value": "1.600", "spread": "0.0361"}, {"groupId": "OG003", "value": "1.591", "spread": "0.0361"}]}]}, {"title": "Day 28/50 min pre-dose (n=171,168,176,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.504", "spread": "0.0353"}, {"groupId": "OG001", "value": "1.458", "spread": "0.0354"}, {"groupId": "OG002", "value": "1.581", "spread": "0.0350"}, {"groupId": "OG003", "value": "1.598", "spread": "0.0351"}]}]}, {"title": "Day 28/15 min pre-dose (n=169,165,174, 170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.529", "spread": "0.0357"}, {"groupId": "OG001", "value": "1.481", "spread": "0.0359"}, {"groupId": "OG002", "value": "1.574", "spread": "0.0354"}, {"groupId": "OG003", "value": "1.584", "spread": "0.0355"}]}]}, {"title": "Day 28/30 min post-dose (n=175,166,174,170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.558", "spread": "0.0362"}, {"groupId": "OG001", "value": "1.457", "spread": "0.0368"}, {"groupId": "OG002", "value": "1.557", "spread": "0.0364"}, {"groupId": "OG003", "value": "1.615", "spread": "0.0364"}]}]}, {"title": "Day 28/30 min post-dose (n=172,167,172,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.566", "spread": "0.0367"}, {"groupId": "OG001", "value": "1.460", "spread": "0.0369"}, {"groupId": "OG002", "value": "1.577", "spread": "0.0368"}, {"groupId": "OG003", "value": "1.593", "spread": "0.0365"}]}]}, {"title": "Day 29/23hr 10 min post-dose (n=172,162,172,168)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.537", "spread": "0.0369"}, {"groupId": "OG001", "value": "1.451", "spread": "0.0376"}, {"groupId": "OG002", "value": "1.604", "spread": "0.0369"}, {"groupId": "OG003", "value": "1.584", "spread": "0.0371"}]}]}, {"title": "Day 29/23hr 45 min post-dose (n=171,161, 175,170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.550", "spread": "0.0370"}, {"groupId": "OG001", "value": "1.438", "spread": "0.0378"}, {"groupId": "OG002", "value": "1.576", "spread": "0.0366"}, {"groupId": "OG003", "value": "1.571", "spread": "0.0369"}]}]}]}, {"type": "SECONDARY", "title": "Forced Expiratory Volume in 1 Second Forced Vital Capacity (FEV1/FVC) Percent at All Time Points", "description": "Forced Expiratory Volume in 1 second (FEV1)/Forced Vital Capacity (FVC) was measured via spirometry conducted according to internationally accepted standards. Data within 6 hr of rescue medication use is excluded from this analysis.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Percent", "timeFrame": "Days 1, 8, 15, 22, 28 and 29 at all time points", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}, {"groupId": "OG001", "value": "172"}, {"groupId": "OG002", "value": "179"}, {"groupId": "OG003", "value": "175"}]}], "classes": [{"title": "Day 1/30 min post-dose (n=172,172,175,173)", "categories": [{"measurements": [{"groupId": "OG000", "value": "65.043", "spread": "0.2548"}, {"groupId": "OG001", "value": "64.898", "spread": "0.2556"}, {"groupId": "OG002", "value": "65.184", "spread": "0.2559"}, {"groupId": "OG003", "value": "64.898", "spread": "0.2554"}]}]}, {"title": "Day 1/1 hr post-dose (n=178,169,174,175)", "categories": [{"measurements": [{"groupId": "OG000", "value": "65.177", "spread": "0.2833"}, {"groupId": "OG001", "value": "64.833", "spread": "0.2890"}, {"groupId": "OG002", "value": "65.005", "spread": "0.2885"}, {"groupId": "OG003", "value": "65.072", "spread": "0.2845"}]}]}, {"title": "Day 8/50 min pre-dose (n=174,171,179,175)", "categories": [{"measurements": [{"groupId": "OG000", "value": "66.566", "spread": "0.4281"}, {"groupId": "OG001", "value": "66.301", "spread": "0.4286"}, {"groupId": "OG002", "value": "67.344", "spread": "0.4222"}, {"groupId": "OG003", "value": "66.568", "spread": "0.4264"}]}]}, {"title": "Day 8/15 min pre-dose (n=176,172,179,174)", "categories": [{"measurements": [{"groupId": "OG000", "value": "66.595", "spread": "0.4259"}, {"groupId": "OG001", "value": "66.790", "spread": "0.4262"}, {"groupId": "OG002", "value": "67.778", "spread": "0.4224"}, {"groupId": "OG003", "value": "67.156", "spread": "0.4252"}]}]}, {"title": "Day 15 /50 min pre-dose (n=176,169,170,169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.007", "spread": "0.4329"}, {"groupId": "OG001", "value": "66.122", "spread": "0.4398"}, {"groupId": "OG002", "value": "67.487", "spread": "0.4395"}, {"groupId": "OG003", "value": "67.139", "spread": "0.4407"}]}]}, {"title": "Day 15/15 min pre-dose (n=176,168,176,167)", "categories": [{"measurements": [{"groupId": "OG000", "value": "66.878", "spread": "0.4370"}, {"groupId": "OG001", "value": "66.006", "spread": "0.4443"}, {"groupId": "OG002", "value": "67.607", "spread": "0.4384"}, {"groupId": "OG003", "value": "67.514", "spread": "0.4456"}]}]}, {"title": "Day 22/50 min pre-dose (n=172,167,174,169)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.081", "spread": "0.4594"}, {"groupId": "OG001", "value": "66.567", "spread": "0.4643"}, {"groupId": "OG002", "value": "67.831", "spread": "0.4584"}, {"groupId": "OG003", "value": "67.742", "spread": "0.4615"}]}]}, {"title": "Day 22/15 min pre-dose (n=169,170,174,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.403", "spread": "0.4657"}, {"groupId": "OG001", "value": "66.885", "spread": "0.4629"}, {"groupId": "OG002", "value": "68.143", "spread": "0.4622"}, {"groupId": "OG003", "value": "67.895", "spread": "0.4612"}]}]}, {"title": "Day 28/50 min pre-dose (n=172,168,176,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.128", "spread": "0.4584"}, {"groupId": "OG001", "value": "66.835", "spread": "0.4615"}, {"groupId": "OG002", "value": "68.124", "spread": "0.4567"}, {"groupId": "OG003", "value": "67.810", "spread": "0.4578"}]}]}, {"title": "Day 28/15 min pre-dose (n=170,165,174, 170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.503", "spread": "0.4813"}, {"groupId": "OG001", "value": "67.296", "spread": "0.4854"}, {"groupId": "OG002", "value": "68.255", "spread": "0.4796"}, {"groupId": "OG003", "value": "67.878", "spread": "0.4804"}]}]}, {"title": "Day 28/30 min post-dose (n=175,166,174,170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.700", "spread": "0.4723"}, {"groupId": "OG001", "value": "67.013", "spread": "0.4796"}, {"groupId": "OG002", "value": "68.031", "spread": "0.4755"}, {"groupId": "OG003", "value": "68.126", "spread": "0.4755"}]}]}, {"title": "Day 28/30 min post-dose (n=173,167,172,172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.945", "spread": "0.4703"}, {"groupId": "OG001", "value": "66.832", "spread": "0.4741"}, {"groupId": "OG002", "value": "68.243", "spread": "0.4736"}, {"groupId": "OG003", "value": "68.057", "spread": "0.4698"}]}]}, {"title": "Day 29/23hr 10 min post-dose (n=173,162,172,168)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.427", "spread": "0.4639"}, {"groupId": "OG001", "value": "66.711", "spread": "0.4736"}, {"groupId": "OG002", "value": "68.265", "spread": "0.4654"}, {"groupId": "OG003", "value": "67.592", "spread": "0.4676"}]}]}, {"title": "Day 29/23hr 45 min post-dose (n=172,161, 175,170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "67.630", "spread": "0.4694"}, {"groupId": "OG001", "value": "66.541", "spread": "0.4806"}, {"groupId": "OG002", "value": "67.961", "spread": "0.4667"}, {"groupId": "OG003", "value": "67.831", "spread": "0.4692"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in Mean Morning and Evening Peak Expiratory Flow Rate (PEFR) Over 4 Weeks of Treatment", "description": "Peak expiratory flow rate (PEFR) was measured via electronice Peak flow meter by patient at home. Mixed model used: change from baseline in the mean evening PEFR = treatment + age + gender + baseline evening PEFR + level of asthma control + region + center (region)+ error. Center is included as a random effect nested within region.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Liters per min", "timeFrame": "Baseline and week 4", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}, {"groupId": "OG001", "value": "172"}, {"groupId": "OG002", "value": "175"}, {"groupId": "OG003", "value": "182"}]}], "classes": [{"title": "Morning 4 wks-baseline (n=177,171, 175, 182)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.952", "spread": "4.1929"}, {"groupId": "OG001", "value": "3.955", "spread": "4.2616"}, {"groupId": "OG002", "value": "2.785", "spread": "4.2349"}, {"groupId": "OG003", "value": "1.606", "spread": "4.1464"}]}]}, {"title": "Evening 4 wks-baseline (n=176, 172, 174, 179)", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.354", "spread": "3.9003"}, {"groupId": "OG001", "value": "0.293", "spread": "3.9477"}, {"groupId": "OG002", "value": "-0.644", "spread": "3.9427"}, {"groupId": "OG003", "value": "6.287", "spread": "3.8826"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in Asthma Control Questionnaire (ACQ-5) by Visit", "description": "Asthma symptoms were evaluated by the Asthma Control Questionnaire (ACQ). The ACQ-5 has five questions of the asthma symptoms to be answered by the patient. The overall score is the average of the 5 questions; a minimum overall score of 0 = good control of asthma whereas a maximum overall score of 6 = poor control of asthma. A negative change in score indicates improvement in symptoms. MIXED model: Change from baseline in ACQ-5 = treatment + gender + baseline ACQ-5 score + age + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region. - Baseline ACQ-5 is defined as the questionnaire completed on Day 1 (randomization).", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Units on a scale", "timeFrame": "Baseline, days 8,15,22 and 29", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "180"}, {"groupId": "OG001", "value": "176"}, {"groupId": "OG002", "value": "182"}, {"groupId": "OG003", "value": "182"}]}], "classes": [{"title": "Day 8-baseline (n=179,176,182,182)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.662", "spread": "0.0543"}, {"groupId": "OG001", "value": "-0.730", "spread": "0.0546"}, {"groupId": "OG002", "value": "-0.908", "spread": "0.0540"}, {"groupId": "OG003", "value": "-0.890", "spread": "0.0538"}]}]}, {"title": "Day 15-baseline(n=180,174,179,178)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.899", "spread": "0.0590"}, {"groupId": "OG001", "value": "-0.908", "spread": "0.0599"}, {"groupId": "OG002", "value": "-1.117", "spread": "0.0595"}, {"groupId": "OG003", "value": "-0.973", "spread": "0.0593"}]}]}, {"title": "Day 22-baseline (n=178,173,178,177)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.994", "spread": "0.0620"}, {"groupId": "OG001", "value": "-0.982", "spread": "0.0628"}, {"groupId": "OG002", "value": "-1.262", "spread": "0.0622"}, {"groupId": "OG003", "value": "-1.097", "spread": "0.0622"}]}]}, {"title": "Day 29-baseline (n=179,176,181,182)", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.079", "spread": "0.0630"}, {"groupId": "OG001", "value": "-1.109", "spread": "0.602"}, {"groupId": "OG002", "value": "-1.329", "spread": "0.0632"}, {"groupId": "OG003", "value": "-1.162", "spread": "0.0625"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in Mean Daily Number of Puffs of Rescue Medication Over 4 Weeks of Treatment", "description": "Rescue medication data recorded during the 14 day run-in period is used to calculate the baseline. - Total number of puffs of rescue medication per day over the full 4 weeks is calculated and divided by the total number of days with non-missing rescue medication data to derive the mean daily number of puffs of rescue medication taken for the subject. - MIXED model: Change = treatment + gender + baseline mean daily number of puffs + age + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "number of puffs", "timeFrame": "Baseline and 4 weeks", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}, {"groupId": "OG001", "value": "172"}, {"groupId": "OG002", "value": "175"}, {"groupId": "OG003", "value": "181"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.456", "spread": "0.0972"}, {"groupId": "OG001", "value": "-0.391", "spread": "0.0985"}, {"groupId": "OG002", "value": "-0.600", "spread": "0.0981"}, {"groupId": "OG003", "value": "-0.677", "spread": "0.0963"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Days With no Rescue Medication Use Over 4 Weeks of Treatment", "description": "Mixed model used: percentage of days with no rescue medication use = treatment + age + gender + baseline percentage of days with no rescue use + level of asthma control + region + center (region) + error. Center is included as a random effect nested within region.\n\nA day with no rescue use is defined from diary data as any day where the subject does not use any puffs of rescue medication.\n\nThe total number of days with no rescue use over the 4 week treatment period is divided by the total number of evaluable days in order to derive the percentage of days with no rescue use.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage days", "timeFrame": "4 weeks", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "124"}, {"groupId": "OG001", "value": "116"}, {"groupId": "OG002", "value": "117"}, {"groupId": "OG003", "value": "113"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "74.148", "spread": "2.2576"}, {"groupId": "OG001", "value": "75.236", "spread": "2.3291"}, {"groupId": "OG002", "value": "75.157", "spread": "2.3044"}, {"groupId": "OG003", "value": "80.578", "spread": "2.3476"}]}]}]}, {"type": "SECONDARY", "title": "Fractional Exhaled Nitric Oxide (FeNO)", "description": "FeNO is widely accepted as a non-invasive marker for airway inflammation such as asthma and conducted according to published guideline. FeNO was measured on days 15 and 29 after treatment.", "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug with available data for analysis.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "ppm", "timeFrame": "Days 15 and 29", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "142"}, {"groupId": "OG001", "value": "143"}, {"groupId": "OG002", "value": "145"}, {"groupId": "OG003", "value": "150"}]}], "classes": [{"title": "Day 15 (n= 142, 139, 139, 149)", "categories": [{"measurements": [{"groupId": "OG000", "value": "25.286", "spread": "1.2983"}, {"groupId": "OG001", "value": "26.762", "spread": "1.3201"}, {"groupId": "OG002", "value": "19.098", "spread": "1.3246"}, {"groupId": "OG003", "value": "21.017", "spread": "1.2911"}]}]}, {"title": "Day 29 (n=141, 143, 145, 150)", "categories": [{"measurements": [{"groupId": "OG000", "value": "23.777", "spread": "1.3078"}, {"groupId": "OG001", "value": "27.055", "spread": "1.3035"}, {"groupId": "OG002", "value": "18.468", "spread": "1.2952"}, {"groupId": "OG003", "value": "19.981", "spread": "1.2803"}]}]}]}, {"type": "SECONDARY", "title": "Plasma Cortisol Concentrations", "description": "Blood samples were taken from each subject participating in the study post dose at day 1 and week 4. Cortisol concentrations were evaluated. Results are presented as nmol/L", "populationDescription": "The safety set includes all subjects who received at least one dose of study drug.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "nmol/L", "timeFrame": "Baseline, days 1 and 28", "groups": [{"id": "OG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening"}, {"id": "OG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening"}, {"id": "OG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening"}, {"id": "OG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "183"}, {"groupId": "OG001", "value": "178"}, {"groupId": "OG002", "value": "179"}, {"groupId": "OG003", "value": "181"}]}], "classes": [{"title": "Baseline (n= 183, 178, 179, 181)", "categories": [{"measurements": [{"groupId": "OG000", "value": "150.040", "spread": "80.3928"}, {"groupId": "OG001", "value": "143.132", "spread": "88.4206"}, {"groupId": "OG002", "value": "143.791", "spread": "85.8696"}, {"groupId": "OG003", "value": "150.108", "spread": "88.6815"}]}]}, {"title": "Day 1/1 Hr (n=179, 177,174, 176)", "categories": [{"measurements": [{"groupId": "OG000", "value": "118.130", "spread": "92.7539"}, {"groupId": "OG001", "value": "106.965", "spread": "81.5160"}, {"groupId": "OG002", "value": "107.526", "spread": "74.3770"}, {"groupId": "OG003", "value": "115.489", "spread": "79.3869"}]}]}, {"title": "Day 28/-25 Mins (n= 172, 169, 174, 172)", "categories": [{"measurements": [{"groupId": "OG000", "value": "140.760", "spread": "73.3567"}, {"groupId": "OG001", "value": "140.604", "spread": "72.8885"}, {"groupId": "OG002", "value": "143.555", "spread": "82.4961"}, {"groupId": "OG003", "value": "145.484", "spread": "92.2940"}]}]}, {"title": "Day 28/1 Hr (n= 172, 168, 174, 170)", "categories": [{"measurements": [{"groupId": "OG000", "value": "105.399", "spread": "68.9416"}, {"groupId": "OG001", "value": "107.931", "spread": "70.7374"}, {"groupId": "OG002", "value": "105.468", "spread": "57.9029"}, {"groupId": "OG003", "value": "110.477", "spread": "77.2220"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "2", "eventGroups": [{"id": "EG000", "title": "Mometasone Furoate 80 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 80 \u03bcg daily in the evening", "seriousNumAffected": 0, "seriousNumAtRisk": 186, "otherNumAffected": 13, "otherNumAtRisk": 186}, {"id": "EG001", "title": "Mometasone Furoate 200 ug Daily Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 200 \u03bcg daily in the evening", "seriousNumAffected": 0, "seriousNumAtRisk": 180, "otherNumAffected": 17, "otherNumAtRisk": 180}, {"id": "EG002", "title": "Mometasone Furoate 320 ug Daily Via the Concept1 Device", "description": "Mometasone furoate (MF) delivered via Concept1, 320 \u03bcg daily in the evening", "seriousNumAffected": 1, "seriousNumAtRisk": 183, "otherNumAffected": 15, "otherNumAtRisk": 183}, {"id": "EG003", "title": "Mometasone Furoate 800 ug Via the Twisthaler\u00ae Device", "description": "Mometasone furoate delivered via Twisthaler\u00ae, 800 \u03bcg daily in the evening", "seriousNumAffected": 0, "seriousNumAtRisk": 186, "otherNumAffected": 8, "otherNumAtRisk": 186}, {"id": "EG004", "title": "Total", "description": "Total", "seriousNumAffected": 1, "seriousNumAtRisk": 735, "otherNumAffected": 53, "otherNumAtRisk": 735}], "seriousEvents": [{"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 16.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 186}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 180}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 183}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 186}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 735}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 16.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 186}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 180}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 183}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 186}, {"groupId": "EG004", "numAffected": 1, "numAtRisk": 735}]}], "otherEvents": [{"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 16.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 186}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 180}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 183}, {"groupId": "EG003", "numAffected": 2, "numAtRisk": 186}, {"groupId": "EG004", "numAffected": 18, "numAtRisk": 735}]}, {"term": "Blood cortisol decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 16.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 186}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 180}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 183}, {"groupId": "EG003", "numAffected": 6, "numAtRisk": 186}, {"groupId": "EG004", "numAffected": 18, "numAtRisk": 735}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 16.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 186}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 180}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 183}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 186}, {"groupId": "EG004", "numAffected": 16, "numAtRisk": 735}]}, {"term": "Oropharyngeal pain", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 16.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 186}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 180}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 183}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 186}, {"groupId": "EG004", "numAffected": 5, "numAtRisk": 735}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial."}, "pointOfContact": {"title": "Clinical Disclosure Office", "organization": "Novartis Pharmaceuticals", "phone": "+1(862)778-8300"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068656", "term": "Mometasone Furoate"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M290", "name": "Mometasone Furoate", "asFound": "Tea", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}